# This Study Aims to Clarify the Prevalence and Characteristics of Neuropathy, Along With Associated Paraclinical Findings in Patients With Waldenström's Macroglobulinemia (WM) in a Cohort of WM Patients to Optimize the Diagnostic Process

> **NCT07160270** · — · RECRUITING · sponsor: **Rigshospitalet, Denmark** · enrollment: 90 (estimated)

## Conditions studied

- Waldenstrom Macroglobulinaemia
- Peripheral Neuropathies

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07160270
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-14
- **Primary completion:** 2025-12-30
- **Final completion:** 2025-12-30
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2025-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07160270

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07160270, "This Study Aims to Clarify the Prevalence and Characteristics of Neuropathy, Along With Associated Paraclinical Findings in Patients With Waldenström's Macroglobulinemia (WM) in a Cohort of WM Patients to Optimize the Diagnostic Process". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT07160270. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*